Department of Emergency Medicine, Far Eastern Memorial Hospital, New Taipei 22056, Taiwan; Graduate Institute of Medicine, Yuan Ze University, Taoyuan 32003, Taiwan; School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei 11031, Taiwan.
Graduate Institute of Basic Medical Science, China Medical University, Taichung 40402, Taiwan; Center for Neuropsychiatry, China Medical University Hospital, Taichung 40402, Taiwan; Department of Social Work, Asia University, Taichung 41354, Taiwan.
Oral Oncol. 2022 May;128:105827. doi: 10.1016/j.oraloncology.2022.105827. Epub 2022 Mar 29.
This study aimed to investigate how different timelines of various dental therapies were related to osteoradionecrosis development under consideration of radiotherapy dosage in patients with oral cancer.
A total of 7,107 oral cancer patients were enrolled, including 88 osteoradionecrosis patients treated with low radiotherapy dosages (<60 Gy) or high radiotherapy dosages (≥60 Gy), from the Longitudinal Health Insurance Database for Catastrophic Illness Patients of Taiwan. Cox proportional hazard regression was used to compare the osteoradionecrosis risk of various dental treatment timelines under different irradiation dosages.
In the oral cancer population with low irradiation dosages (<60 Gy), performing periodontal therapy combined with irradiation significantly raised the risk of osteoradionecrosis by 2.21-fold. Starting radiotherapy within three months after dental surgery greatly increased the risk of developing osteoradionecrosis by 1.87-fold. The oral cancer patients treated with high radiation doses (≥60 Gy) receiving dental surgery within one month prior to radiotherapy had a significantly raised osteoradionecrosis occurrence by 1.60-fold. While the dental surgery was performed during the radiotherapy course, the risk of osteoradionecrosis was greatly increased by 2.21-fold.
For oral cancer patients, performing dental surgery within three months before radiotherapy might significantly induce osteoradionecrosis. Patients that were treated with high irradiation dosages (≥60 Gy) had a higher tendency to develop osteoradionecrosis if they received dental surgery during radiotherapy. Those who were treated with low radiation dosages (<60 Gy) and received periodontal therapy during radiotherapy might have an increased risk in developing osteoradionecrosis.
本研究旨在探讨在考虑口腔癌患者放射剂量的情况下,不同牙科治疗方案的时间线如何与放射性骨坏死的发展相关。
共纳入了 7107 例口腔癌患者,包括 88 例接受低放射剂量(<60Gy)或高放射剂量(≥60Gy)治疗的放射性骨坏死患者,这些患者均来自台湾灾难性疾病医疗保险数据库。使用 Cox 比例风险回归比较了不同照射剂量下不同牙科治疗方案的放射性骨坏死风险。
在低照射剂量(<60Gy)的口腔癌患者中,牙周治疗与放疗联合进行会使放射性骨坏死的风险增加 2.21 倍。在牙科手术后三个月内开始放疗会使放射性骨坏死的风险增加 1.87 倍。在接受高放射剂量(≥60Gy)治疗的口腔癌患者中,在放疗前一个月内进行牙科手术会使放射性骨坏死的发生风险增加 1.60 倍。在放疗过程中进行牙科手术,放射性骨坏死的风险会大大增加 2.21 倍。
对于口腔癌患者,在放疗前三个月内进行牙科手术可能会显著诱导放射性骨坏死。接受高放射剂量(≥60Gy)治疗的患者如果在放疗期间接受牙科手术,则发生放射性骨坏死的风险更高。那些接受低放射剂量(<60Gy)且在放疗期间接受牙周治疗的患者可能会增加放射性骨坏死的风险。